Inspire Medical Systems, Inc. (INSP)
Inspire Medical Systems, Inc. (INSP) from its SEC filings: 2025 revenue $912.0 million (+14% vs the year before), net margin 16%, free cash flow $78.5 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $912.0 million |
| Revenue growth | +14% |
| Net income | $145.4 million |
| Net margin | 15.9% |
| Free cash flow | $78.5 million |
| Diluted EPS | $4.89 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -8% |
| Cash | $127.8 million |
| Long-term debt | $21.4 million |
| Share count, 1 year | -2% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.